Newsroom
Top Results
Event: American Academy of Optometry (AAOpt)
Event Details November 3-6 Boston, MA Contact Sight Sciences today to schedule a meeting.
Event: Vision Expo West (VEW)
Event Details September 22-25 Las Vegas, NV Contact Sight Sciences today to schedule a meeting.
Event: American Optometric Association (AOA)
Event Details June 24-27 Anaheim, CA Contact Sight Sciences today to schedule a meeting.
Event: American Society for Cataract and Refractive Surgeons (ASCRS)
Event Details July 23-27 Las Vegas, NV Contact Sight Sciences today to schedule a meeting.
Event: Vision Source Exchange (VSE)
Event Details August 4-7 Houston, TX Contact Sight Sciences today to schedule a meeting.
Event: Vision Expo East (VEE)
Event Details June 2-5 Orlando, FL Contact Sight Sciences today to schedule a meeting.
Sight Sciences Receives Full Investigational Device Exemption (IDE) Approval from the US FDA to Initiate the VISCO™360 Versus SLT Glaucoma Trial
Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received full IDE approval from the FDA to initiate the world’s first clinical trial comparing ab interno canaloplasty with Selective Laser Trabeculoplasty (SLT). The VISCO™360 versus SLT Glaucoma Trial is a multi-center, prospective, randomized, controlled clinical evaluation that will study […]
Sight Sciences Announces the Closing of its $7MM Series B Financing Led by Hicks Equity Partners
Sight Sciences, Inc., a venture-backed, commercial stage ophthalmic medical device company today announced it has closed a $7 million Series B round of financing. The round was led by Hicks Equity Partners, a leading private equity firm based in Dallas, Texas. All Series A investors participated in the oversubscribed Series B round, including Scientific Health […]